Batya Plotkin

Title: Batya Plotkin: Innovator in Glycogen Synthase Kinase-3 Inhibitors

Introduction

Batya Plotkin is a notable inventor based in Rishon-LeZion, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of novel peptide inhibitors targeting glycogen synthase kinase-3 (GSK-3). His work has implications for various therapeutic applications.

Latest Patents

Batya Plotkin holds a patent for "Glycogen synthase kinase-3 inhibitors - Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof." This patent describes substrate-competitive inhibitors that have an amino acid sequence specifically designed to bind to a defined binding site subunit in GSK-3. The invention also includes GSK-3 substrate competitive inhibitors that interact with the defined binding site subunit in the enzyme. Additionally, the patent discusses mutants of GSK-3 and their uses for identifying potential GSK-3 substrate competitive inhibitors. He has 1 patent to his name.

Career Highlights

Batya Plotkin is associated with Ramot at Tel-Aviv University Ltd., where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.

Collaborations

Batya has collaborated with notable colleagues, including Hagit Eldar-Finkelman and Avital Licht-Murava, who have contributed to his research endeavors.

Conclusion

Batya Plotkin's contributions to the development of GSK-3 inhibitors highlight his role as an innovator in biochemistry. His work not only advances scientific understanding but also opens new avenues for therapeutic interventions.